Clinical Trial Update: A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events [Phase 2]

View source ↗

Summary

Phase 2 trial of LY3473329 in adults with elevated lipoprotein(a) at high risk for cardiovascular events has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hyperlipoproteinemia

Drugs mentioned

• LY3473329

Snippet

Sponsor: Eli Lilly and Company | Conditions: Lipoprotein Disorder | Phase 2 | Status: COMPLETED | Results posted: 2025-03-25